Latest Capital Raising News

Nex Metals Explorations has repriced and partially completed its capital raise, securing $1.06 million at a reduced share price to fund development and exploration activities.

Vonex Limited has vested performance rights for its CEO and directors following MaxoTel’s acquisition of majority control, with shares set to be sold on-market. The company reports a mixed 1H FY25 financial performance and is exploring options to repay a $23 million debt facility, including a potential capital raise.

Centrex Limited has initiated a $10.4 million entitlement offer to fund essential plant upgrades and strengthen working capital, following a strategic logistics debt restructuring. The raise is pivotal for advancing the Ardmore phosphate project and maintaining financial viability.

Mesoblast has raised A$260 million through a global private placement to fund the US commercial launch of its FDA-approved cell therapy Ryoncil® and accelerate clinical development in chronic low back pain.

Magnetic Resources NL reported a $4.39 million net cash outflow from operations in Q4 2024 but strengthened its balance sheet with a $9.41 million financing inflow, ending the quarter with $11.6 million in cash.

The Australian Takeovers Panel has declared unacceptable circumstances in Alara Resources Limited's recent rights issue, citing inadequate disclosure and potential control issues involving Al Tasnim Infrastructure LLC. The company faces a costs order and must reassess its fundraising approach.

McLaren Minerals has successfully raised $1.5 million through a shortfall placement, bolstering its efforts to advance the Pre-Feasibility Study for its McLaren Mineral Sands Project in Western Australia.

DomaCom Limited has announced a $1.5 million placement to Lumiere Lifestyle Group, alongside the launch of three innovative funds targeting care and disability accommodation sectors, reinforcing its growth strategy and financial position.

New Zealand Coastal Seafoods has detailed the terms of its recent $270,000 convertible note subscription following an ASX inquiry, confirming lender identities, conversion pricing, and compliance with disclosure rules.

Calix Limited has extended its Share Purchase Plan closing date to January 31, 2025, offering eligible shareholders more time to invest up to $30,000 each. The company may close the plan early if subscriptions exceed $5 million, signaling strong investor interest in its decarbonisation technology.

Way 2 Vat Ltd's trading suspension is scheduled to end on 13 January 2025, coinciding with the announcement of a proposed capital raising that could reshape its financial outlook.

Way2VAT has locked in A$1.3 million through convertible notes aimed at bolstering working capital and accelerating client expansion, pending shareholder approval for conversion.